Medical biotechnology industry

A man walks outside the Biogen Inc., headquarters, Wednesday, March 11, 2020, in Cambridge, Mass. Seventy of Massachusetts' 92 confirmed coronavirus cases have been linked to a meeting of Biogen executives that was held at the Marriott Long Wharf hotel in Boston in late February 2020. For most people, the virus causes only mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia. The vast majority of people recover from the new virus. (AP Photo/Steven Senne)
March 11, 2020 - 5:12 pm
BOSTON (AP) — A biotech meeting at a hotel in downtown Boston appears to be the source of a cluster of the coronavirus in the U.S. — and a warning for employers who are still holding big gatherings as the outbreak spreads. Seventy-seven of the 95 confirmed cases in Massachusetts have been linked to...
Read More
Passengers from the Grand Princess, a cruise ship carrying multiple people who have tested positive for COVID-19, exit a bus before boarding a chartered plane in Oakland, Calif., Tuesday, March 10, 2020. The passengers on the flight are going to San Antonio to be quarantined at Lackland Air Force Base. (AP Photo/Jeff Chiu)
AP News
March 11, 2020 - 1:34 am
Alarming clusters of the coronavirus swelled on both coasts of the U.S. on Tuesday, with more than 70 cases now tied to a biotech conference in Boston and infections turning up at 10 nursing homes in the hard-hit Seattle area. Presidential candidates Bernie Sanders and Joe Biden abruptly canceled...
Read More
November 24, 2019 - 5:06 pm
Swiss pharmaceutical company Novartis has reached a deal to buy cholesterol drugmaker The Medicines Co. for $9.7 billion. Novartis will pay $85 per share for the New Jersey biotech company, a sharp increase over The Medicine Co.’s Friday closing price of $68.55 per share. The deal is worth $9.7...
Read More
FILE - This Dec. 4, 2017, file photo shows the Pfizer company logo at the company's headquarters in New York. Pfizer is buying the cancer treatment company Array BioPharma in a deal worth $11.4 billion. Array has a combination therapy for BRAF-mutant metastatic melanoma, along with a pipeline of targeted cancer medicines in development and a portfolio of other medicines that are expected to generate significant royalties over time. (AP Photo/Richard Drewm Fuke, File)
June 17, 2019 - 8:28 am
NEW YORK (AP) — Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring. Pfizer said Monday it will pay $48 per share in cash for Array,...
Read More
FILE - In this Oct. 9, 2018, file photo, Zhou Xiaoqin installs a fine glass pipette into a sperm injection microscope in preparation for injecting embryos with Cas9 protein and PCSK9 sgRNA at a lab in Shenzhen in southern China's Guandong province. China has unveiled draft regulations on gene-editing and other new biomedical technologies it considers to be "high-risk." The measures follow claims in November 2018 by Chinese scientist He Jiankui that he helped make the world's first genetically-edited babies. That roiled the global science community and elicited widespread outcry over the procedure's ethical implications. (AP Photo/Mark Schiefelbein, File)
February 27, 2019 - 3:29 am
BEIJING (AP) — China has unveiled draft regulations on gene editing and other potentially risky biomedical technologies after a Chinese scientist's claim of helping to create gene-edited babies roiled the global science community. Under the proposed measures released Tuesday, technology involving...
Read More
February 25, 2019 - 8:29 am
BOSTON (AP) — General Electric is selling its biopharma business to Danaher Corp. for $21.4 billion as it continues to sell off chunks of a once sprawling conglomerate. The biopharma unit, part of GE Life Sciences, generated revenue of about $3 billion last year. Danaher said after tax benefits,...
Read More
FILE- In this Nov. 20, 2018, file photo pedestrians walk past the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EST on Friday, Nov. 30 (AP Photo/Mary Altaffer, File)
November 30, 2018 - 4:40 pm
NEW YORK (AP) — Stocks climbed again Friday as investors waited for President Donald Trump and President Xi Jinping of China to meet and discuss trade, a meeting they hope will start to resolve the nations' trade dispute. The U.S. market jumped this week after falling to a six-month low the week...
Read More
Republican U.S. Rep. Christopher Collins, center, leaves federal court, Wednesday, Aug. 8, 2018, in New York. Rep. Collins of western New York state has been indicted on charges that he used inside information about a biotechnology company to make illicit stock trades (AP Photo/Mary Altaffer)
August 09, 2018 - 2:17 am
NEW YORK (AP) — The Latest on insider-trading charges filed against U.S. Rep. Chris Collins (all times local): 8:20 p.m. Republican U.S. Rep. Chris Collins says he will remain on the ballot running for re-election in New York as he fights charges that he used inside information about a...
Read More
Republican U.S. Rep. Christopher Collins, center, leaves federal court, Wednesday, Aug. 8, 2018, in New York. Rep. Collins of western New York state has been indicted on charges that he used inside information about a biotechnology company to make illicit stock trades (AP Photo/Mary Altaffer)
August 09, 2018 - 12:24 am
NEW YORK (AP) — Republican U.S. Rep. Christopher Collins of New York was arrested Wednesday on charges he fed inside information he gleaned from sitting on the board of a biotechnology corporation to his son, helping family and friends dodge hundreds of thousands of dollars in losses when one of...
Read More
This undated microscope image provided by the American Society for Reproductive Medicine in January 2018 shows a trophectoderm biopsy, in which cells from the outer layer of an embryo that develop into the placenta and amniotic membranes are removed and can be used for genetic testing. When a couple is known to be at risk for having a child with a specific genetic disorder, the woman undergoes a procedure to remove some of her eggs. After fertilization, some cells can be plucked from the embryos and examined to identify those without carry the disease-causing abnormality. (ASRM via AP)Wedn
April 18, 2018 - 9:28 am
NEW YORK (AP) — So you want to have a baby. Would you like a dark-haired girl with a high risk of someday getting colon cancer, but a good chance of above-average music ability? Or would you prefer a girl with a good prospect for high SAT scores and a good shot at being athletic, but who also is...
Read More

Pages